ONYX HARAN: Open Payments
NPI 1740942317 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 26 payments from 9 companies in 2025. Trend: 2023 $231 · 2024 $1,429 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $263 |
| Organon LLC | 5 | $161 |
| Galderma Laboratories, L.P. | 3 | $69 |
| ABBVIE INC. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Janssen Biotech, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $31 |
| UCB, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: DUPIXENT, VTAMA, NEMLUVIO, COSENTYX, SKYRIZI, TREMFYA, OTEZLA, RINVOQ.
Industry payments across GA — which companies pay providers there.
